Ticker brief
GANX
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
13
authors 14d
10
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-29 → 2026-07-02 · now +0.25 (−1 bearish … +1 bullish)
Who spoke10
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @AlertsAndNews | C | +1.52 | 2 | +0.35 |
| @TheBreakoutZone | C | -1.32 | 2 | +0.47 |
| @abc51648039 | C | +1.80 | 2 | +0.20 |
| @Bezel4455 | C | -2.52 | 1 | +0.60 |
| @EmmanuelInvest | C | -1.12 | 1 | +0.50 |
| @OzmosiHealth | C | · | 1 | +0.50 |
| @USAnt_IDEA | C | -0.65 | 1 | +0.50 |
| @MrGannabc | C | -1.00 | 1 | +0.40 |
| @BiopharmIQ | B | · | 1 | +0.15 |
| @perry_lin1 | B | -0.51 | 1 | +0.25 |
Recent signals13of 13 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @perry_lin1 | +0.25 | Ticker with prayer emoji implies a bullish hope but no thesis. | · | tweet ↗ |
| 2026-06-30 | @BiopharmIQ | +0.15 | Biotech open news list with positive percentage moves and catalysts. | · | tweet ↗ |
| 2026-06-30 | @abc51648039 | +0.20 | Arabic watch-only post gives upside trigger above 2.51 and support/break level 2.01. | · | tweet ↗ |
| 2026-06-30 | @abc51648039 | +0.20 | Arabic watch-only post gives upside trigger above 2.51 and support/break level 2.01. | · | tweet ↗ |
| 2026-06-30 | @MrGannabc | +0.40 | Arabic premarket watchlist with breakout, target and stop levels; not framed as buy/sell recommendation. | · | tweet ↗ |
| 2026-06-29 | @AlertsAndNews | +0.20 | Recaps multiple alerts, entries, targets and gains already hit. | · | tweet ↗ |
| 2026-06-29 | @USAnt_IDEA | +0.50 | Korean biotech pipeline roundup cites FDA approvals, trial starts, and results. | · | tweet ↗ |
| 2026-06-29 | @TheBreakoutZone | +0.45 | After-hours alerts already moved from alert prices to highs; recap of realized performance. | · | tweet ↗ |
| 2026-06-29 | @OzmosiHealth | +0.50 | Gain Therapeutics receives FDA IND clearance to advance GT-02287 into Phase 2. | · | tweet ↗ |
| 2026-06-29 | @EmmanuelInvest | +0.50 | Gain Therapeutics gets FDA IND clearance for GT-02287 in Parkinson's. | · | tweet ↗ |
| 2026-06-29 | @Bezel4455 | +0.60 | GANX receives FDA IND clearance for GT-02287 in Parkinson's disease. | · | tweet ↗ |
| 2026-06-29 | @TheBreakoutZone | +0.50 | GANX receives FDA IND clearance to advance GT-02287 into Phase 2. | · | tweet ↗ |
| 2026-06-29 | @AlertsAndNews | +0.50 | Gain Therapeutics receives FDA IND clearance to advance GT-02287 into Phase 2 for Parkinson's. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.